Tafas V. Doll: Repercussions Of En Banc

Law360, New York (September 17, 2009, 12:44 PM EDT) -- On July 6, 2009, the U.S. Court of Appeals for the Federal Circuit vacated its previous decision, Tafas v. Doll, 559 F.3d 1345 (Fed. Cir. 2009), in order to hear the case en banc.[1]

The en banc hearing will be based on the petitions filed by the appellees Triantafyllos Tafas and GlaxoSmithKline[2] and additional briefing by all the parties to be filed within 30 days.

On a practical level, the en banc hearing will test the authority of the U.S. Patent and Trademark Office to implement...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.